MPM BioImpact’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.5M Buy
+771,839
New +$27.5M 1.59% 30

Other funds holding NGNE

MPM BioImpact's NGNE Position: Q3 2026 in Review

MPM BioImpact opened a new position in Neurogene (NGNE) in Q3 2026: 771,839 shares worth $21.5M. The stake represents 1.59% of the portfolio and ranks #30 among its holdings.

132 funds tracked by Wall St. Rank hold NGNE as of Q3 2026.

  • MPM BioImpact held 771,839 shares of Neurogene worth $21.5M as of Q3 2026.
  • Neurogene was a new MPM BioImpact position in Q3 2026.
  • Neurogene made up 1.59% of MPM BioImpact's portfolio in Q3 2026, its #30 holding.
  • 132 funds tracked by Wall St. Rank held Neurogene as of Q3 2026.

Based on MPM BioImpact's 13F filing for Q3 2026, filed 16 Nov 2026.